Personal information

No personal information available

Activities

Collapse all

Works (42)

Detection of SARS-CoV-2 RNA and biomarkers in device-captured droplets from the lung

CHEST Pulmonary
2025-01 | Journal article
DOI: 10.1016/j.chpulm.2025.100137
Contributors: Rebecca S. Steinberg; Tzu-Chun Chu; Denny Shin; Binh Ha; He-Ying Sun; Samadhan J. Jadhao; David N. Ku; Blaine R. Roberts; Evan J. Anderson; Laila Hussaini et al.
Source: check_circle
Crossref

Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States

The Journal of Infectious Diseases
2024-12-16 | Journal article
DOI: 10.1093/infdis/jiae346
Contributors: Evan J Anderson; Ashley Tippett; Elizabeth Begier; Theda Gibson; Gabby Ess; Vikash Patel; Meg Taylor; Olivia Reese; Luis Salazar; Samadhan Jadhao et al.
Source: check_circle
Crossref

Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

Nature Communications
2024-08-29 | Journal article
DOI: 10.1038/s41467-024-50376-z
Contributors: Lindsey R. Baden; Hana M. El Sahly; Brandon Essink; Dean Follmann; Gregory Hachigian; Cynthia Strout; J. Scott Overcash; Susanne Doblecki-Lewis; Jennifer A. Whitaker; Evan J. Anderson et al.
Source: check_circle
Crossref

Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study

Vaccines
2024-06 | Journal article | Author
DOI: 10.3390/vaccines12060657
Contributors: Amy Keane; Ashley Tippett; Elizabeth Grace Taylor; Olivia Reese; Luis Salazar; Khalel De Castro; Jong-Ha Choi; Caroline Ciric; Meg Taylor; Anna Mitchell et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Long-term safety and efficacy of COVE study open-label and booster phases

2024-03-14 | Preprint
DOI: 10.21203/rs.3.rs-3900939/v1
Contributors: Lindsey Baden; Hana El Sahly; Brandon Essink; Dean Follmann; Gregory Hachigian; Cynthia Strout; J. Scott Overcash; Susanne Doblecki-Lewis; Jennifer Whitaker; Evan Anderson et al.
Source: check_circle
Crossref

Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults

Vaccine
2024-01 | Journal article
DOI: 10.1016/j.vaccine.2023.12.001
Contributors: Lisa A. Jackson; Jack T. Stapleton; Emmanuel B. Walter; Wilbur H. Chen; Nadine G. Rouphael; Evan J. Anderson; Kathleen M. Neuzil; Patricia L. Winokur; Michael J. Smith; Kenneth E. Schmader et al.
Source: check_circle
Crossref

SARS-CoV-2 Antibody Profiles in Maternal Serum and Breast Milk Following mRNA COVID-19 Vaccination: A Longitudinal Prospective Observational Cohort Study

Vaccines
2023-10-26 | Journal article
DOI: 10.3390/vaccines11111643
Contributors: Hui-Mien Hsiao; Langdon S. DiMaggio; Maria A. Perez; Xuemin Chen; Kathleen Stephens; Theda Gibson; Evan J. Anderson; Christina A. Rostad
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine
2023-09 | Journal article
DOI: 10.1038/s41591-023-02503-4
Contributors: Angela R. Branche; Nadine G. Rouphael; David J. Diemert; Ann R. Falsey; Cecilia Losada; Lindsey R. Baden; Sharon E. Frey; Jennifer A. Whitaker; Susan J. Little; Evan J. Anderson et al.
Source: check_circle
Crossref

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

2023-05-05 | Preprint
DOI: 10.21203/rs.3.rs-2653179/v1
Contributors: Angela Branche; Nadine Rouphael; David Diemert; Ann Falsey; Cecilia Losada; Lindsey (R) Baden; Sharon Frey; Jennifer Whitaker; Susan Little; Evan Anderson et al.
Source: check_circle
Crossref

Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022

Influenza and Other Respiratory Viruses
2023-03 | Journal article
DOI: 10.1111/irv.13107
Contributors: Melisa M. Shah; Kadam Patel; Jennifer Milucky; Christopher A. Taylor; Arthur Reingold; Isaac Armistead; James Meek; Evan J. Anderson; Andy Weigel; Libby Reeg et al.
Source: check_circle
Crossref

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

2023-02-02 | Preprint
DOI: 10.1101/2023.01.31.23285306
Contributors: Angela R. Branche; Nadine G. Rouphael; Cecilia Losada; Lindsey R. Baden; Evan J. Anderson; Anne F. Luetkemeyer; David J. Diemert; Patricia L. Winokur; Rachel M. Presti; Angelica C. Kottkamp et al.
Source: check_circle
Crossref

Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019

Influenza and Other Respiratory Viruses
2023-01 | Journal article
DOI: 10.1111/irv.13052
Contributors: Christina E. Parisi; Kimberly Yousey‐Hindes; Rachel Holstein; Alissa O'Halloran; Pam Dailey Kirley; Nisha B. Alden; Evan J. Anderson; Sue Kim; Melissa McMahon; Sarah A. Khanlian et al.
Source: check_circle
Crossref

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-Up Compared With Natural Infection

2022-12-07 | Other
DOI: 10.1093/infdis/jiac482
Contributors: Camilo J Acosta; Evan J. Anderson; Clemente Diaz
Source: check_circle
Crossref

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

New England Journal of Medicine
2022-11-03 | Journal article
DOI: 10.1056/NEJMoa2209367
Contributors: Evan J. Anderson; C. Buddy Creech; Vladimir Berthaud; Arin Piramzadian; Kimball A. Johnson; Marcus Zervos; Fredric Garner; Carl Griffin; Khozema Palanpurwala; Mark Turner et al.
Source: check_circle
Crossref

Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination

The Journal of Infectious Diseases
2022-09-28 | Journal article
DOI: 10.1093/infdis/jiac215
Contributors: Christina A Rostad; Xuemin Chen; He ying Sun; Laila Hussaini; Austin Lu; Maria A Perez; Hui Mien Hsiao; Larry J Anderson; Evan J Anderson
Source: check_circle
Crossref

An RSV live-attenuated vaccine candidate lacking G protein mucin domains is attenuated, immunogenic, and effective in preventing RSV in BALB/c mice

2022-09-27 | Other
DOI: 10.1093/infdis/jiac382
Contributors: Christina A. Rostad; He-Ying Sun; Larry J. Anderson; Anne Piantadosi; Evan J. Anderson
Source: check_circle
Crossref

Addressing the global burden of paediatric critical COVID-19 and mortality

The Lancet Regional Health - Americas
2022-08 | Journal article
DOI: 10.1016/j.lana.2022.100301
Contributors: Satoshi Kamidani; Christina A. Rostad; Evan J. Anderson
Source: check_circle
Crossref

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

2022-07-15 | Preprint
DOI: 10.1101/2022.07.12.22277336
Contributors: Angela R. Branche; Nadine G. Rouphael; David J. Diemert; Ann R. Falsey; Cecilia Losada; Lindsey R. Baden; Sharon E. Frey; Jennifer A. Whitaker; Susan J. Little; Evan J. Anderson et al.
Source: check_circle
Crossref

Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007–2018

Open Forum Infectious Diseases
2022-07-04 | Journal article
DOI: 10.1093/ofid/ofac276
Contributors: Eric W Hall; Ashley Tippett; Scott Fridkin; Evan J Anderson; Ben Lopman; David Benkeser; Julia M Baker
Source: check_circle
Crossref

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

New England Journal of Medicine
2022-05-26 | Journal article
DOI: 10.1056/NEJMoa2203315
Contributors: C. Buddy Creech; Evan Anderson; Vladimir Berthaud; Inci Yildirim; Andrew M. Atz; Ivan Melendez Baez; Daniel Finkelstein; Paul Pickrell; Judith Kirstein; Clifford Yut et al.
Source: check_circle
Crossref

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine — An Interim Analysis

2022-05-03 | Preprint
DOI: 10.21203/rs.3.rs-1222037/v1
Contributors: Evan Anderson; Lisa Jackson; Nadine Rouphael; Alicia Widge; David Montefiori; Nicole Doria-Rose; Mehul Suthar; Kristen Cohen; Sarah O'Connell; Mat Makowski et al.
Source: check_circle
Crossref

Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes—Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2017

Open Forum Infectious Diseases
2022-05-01 | Journal article
DOI: 10.1093/ofid/ofac131
Contributors: Daniel Owusu; Melissa A Rolfes; Carmen S Arriola; Pam Daily Kirley; Nisha B Alden; James Meek; Evan J Anderson; Maya L Monroe; Sue Kim; Ruth Lynfield et al.
Source: check_circle
Crossref

Reply to Rose et al

Clinical Infectious Diseases
2022-01-07 | Journal article
DOI: 10.1093/cid/ciab400
Contributors: Evan J Anderson; Satoshi Kamidani; Walt Orenstein; James D Campbell
Source: check_circle
Crossref

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine
2021-11-04 | Journal article
DOI: 10.1056/NEJMoa2113017
Contributors: Hana M. El Sahly; Lindsey R. Baden; Brandon Essink; Susanne Doblecki-Lewis; Judith M. Martin; Evan J. Anderson; Thomas B. Campbell; Jesse Clark; Lisa A. Jackson; Carl J. Fichtenbaum et al.
Source: check_circle
Crossref

Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey

Vaccines
2021-09-21 | Journal article
DOI: 10.3390/vaccines9091049
Contributors: Mehgan Teherani; Samridhi Banskota; Andres Camacho-Gonzalez; Alison G. C. Smith; Evan J. Anderson; Carol M. Kao; Charles Crepy D’Orleans; Andi L. Shane; Austin Lu; Preeti Jaggi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science
2021-09-17 | Journal article
DOI: 10.1126/science.abj4176
Contributors: Amarendra Pegu; Sarah E. O’Connell; Stephen D. Schmidt; Sijy O’Dell; Chloe A. Talana; Lilin Lai; Jim Albert; Evan Anderson; Hamilton Bennett; Kizzmekia S. Corbett et al.
Source: check_circle
Crossref

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein

Virology
2021-07 | Journal article
DOI: 10.1016/j.virol.2021.03.009
Contributors: Xuemin Chen; Christina A. Rostad; Larry J. Anderson; He-ying Sun; Stacey A. Lapp; Kathy Stephens; Laila Hussaini; Theda Gibson; Nadine Rouphael; Evan J. Anderson
Source: check_circle
Crossref

Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?

Clinical Infectious Diseases
2021-07-15 | Journal article
DOI: 10.1093/cid/ciaa1425
Contributors: Evan J Anderson; James D Campbell; C Buddy Creech; Robert Frenck; Satoshi Kamidani; Flor M Munoz; Sharon Nachman; Paul Spearman
Source: check_circle
Crossref

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

2021-05-16 | Other
DOI: 10.1101/2021.05.13.444010
Contributors: Amarendra Pegu; Sarah O’Connell; Stephen D Schmidt; Sijy O’Dell; Chloe A. Talana; Lilin Lai; Jim Albert; Evan Anderson; Hamilton Bennett; Kizzmekia S. Corbett et al.
Source: check_circle
Crossref

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

Vaccine
2021-02 | Journal article
DOI: 10.1016/j.vaccine.2020.11.051
Contributors: Patricia Winokur; Hana M. El Sahly; Mark J. Mulligan; Sharon E. Frey; Richard Rupp; Evan J. Anderson; Kathryn M. Edwards; David I. Bernstein; Kenneth Schmader; Lisa A. Jackson et al.
Source: check_circle
Crossref

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

New England Journal of Medicine
2021-01-07 | Journal article
DOI: 10.1056/NEJMc2032195
Contributors: Alicia T. Widge; Nadine G. Rouphael; Lisa A. Jackson; Evan J. Anderson; Paul C. Roberts; Mamodikoe Makhene; James D. Chappell; Mark R. Denison; Laura J. Stevens; Andrea J. Pruijssers et al.
Source: check_circle
Crossref

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

New England Journal of Medicine
2020-12-17 | Journal article
DOI: 10.1056/NEJMoa2028436
Contributors: Evan J. Anderson; Nadine G. Rouphael; Alicia T. Widge; Lisa A. Jackson; Paul C. Roberts; Mamodikoe Makhene; James D. Chappell; Mark R. Denison; Laura J. Stevens; Andrea J. Pruijssers et al.
Source: check_circle
Crossref

COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020

Open Forum Infectious Diseases
2020-11-01 | Journal article
DOI: 10.1093/ofid/ofaa528
Contributors: Anna M Acosta; Adria L Mathis; Daniel S Budnitz; Andrew I Geller; Shua J Chai; Nisha B Alden; James Meek; Evan J Anderson; Patricia Ryan; Sue Kim et al.
Source: check_circle
Crossref

Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults

Annals of Internal Medicine
2020-10-20 | Journal article
DOI: 10.7326/M20-1509
Contributors: Eric J. Chow; Melissa A. Rolfes; Alissa O'Halloran; Evan J. Anderson; Nancy M. Bennett; Laurie Billing; Shua Chai; Elizabeth Dufort; Rachel Herlihy; Sue Kim et al.
Source: check_circle
Crossref

Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination

Vaccines
2020-07 | Journal article | Author
DOI: 10.3390/vaccines8030414
Contributors: Kristal Maner-Smith; Johannes B. Goll; Manoj Khadka; Travis L. Jensen; Jennifer K. Colucci; Johannes B. Goll; Travis L. Jensen; Steven E. Bosinger; Jacob D. Franke; Muktha Natrajan et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine

Vaccines
2020-07-24 | Journal article
DOI: 10.3390/vaccines8030413
Contributors: Yie-Hwa Chang; Duc M. Duong; Johannes B. Goll; David C. Wood; Travis L. Jensen; Luming Yin; Casey E. Gelber; Nicholas T. Seyfried; Evan Anderson; Muktha S. Natrajan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine

Vaccines
2020-07-24 | Journal article
DOI: 10.3390/vaccines8030412
Contributors: Johannes B. Goll; Shuzhao Li; James L. Edwards; Steven E. Bosinger; Travis L. Jensen; Yating Wang; William F. Hooper; Casey E. Gelber; Katherine L. Sanders; Evan J. Anderson et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure

Vaccines
2020-06-30 | Journal article
DOI: 10.3390/vaccines8030348
Contributors: Lilin Lai; Kevin Ault; Nadine Rouphael; Allison Beck; Briyana Domjahn; Yongxian Xu; Evan J. Anderson; Andrew Cheng; Aya Nakamura; Rebecca J. Hoagland et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine

Vaccines
2020-03-13 | Journal article
DOI: 10.3390/vaccines8010126
Contributors: Lilin Lai; Nadine Rouphael; Yongxian Xu; Amy C. Sherman; Srilatha Edupuganti; Evan J. Anderson; Pamela Lankford-Turner; Dongli Wang; Wendy Keitel; Monica M. McNeal et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine

Vaccines
2020-02-06 | Journal article
DOI: 10.3390/vaccines8010069
Contributors: Evan J. Anderson; Lilin Lai; Jens Wrammert; Sarah Kabbani; Yongxian Xu; Lalita Priyamvada; Heather Hill; Johannes B. Goll; Travis L. Jensen; Carol Kao et al.
Source: check_circle
Crossref

Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses

Vaccines
2019-12 | Journal article | Author
DOI: 10.3390/vaccines8010004
Contributors: Muktha S. Natrajan; Nadine Rouphael; Lilin Lai; Dmitri Kazmin; Travis L. Jensen; David S. Weiss; Chris Ibegbu; Marcelo B. Sztein; William F. Hooper; Heather Hill et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Hospitalization Is an Underutilized Opportunity to Vaccinate for Influenza

Mayo Clinic Proceedings
2019-03 | Journal article
DOI: 10.1016/j.mayocp.2019.01.012
Contributors: Evan J. Anderson; Carol Kao; Inci Yildirim
Source: check_circle
Crossref
How many people are using ORCID?